CISION PRNewswire

43407 posts

KIND Presents Preclinical Results of AND017 in Animal Models of Sickle Cell Disease (SCD), Myelodysplastic Syndromes (MDS), and β-Thalassemia at the 66th American Society of Hematology Meeting and Exposition and Announces FDA Authorization of Investigational New Drug (IND) Application for AND017 for Clinical Trial in Sickle Cell Disease (SCD)

SAN FRANCISCO, Dec. 12, 2024 /PRNewswire/ — Kind Pharmaceutical ("Hangzhou Andao Pharmaceutical Ltd.…

Waterdrop Inc. Announces Third Quarter 2024 Unaudited Financial Results, Net profit rises 152.6% year-on-year

BEIJING, Dec. 12, 2024 /PRNewswire/ — On December 11, 2024, Waterdrop Inc.…
Air France expands network with 3 weekly non-stop flight between Manila and Paris

Air France expands network with 3 weekly non-stop flight between Manila and Paris

MANILA, Philippines, Dec. 12, 2024 /PRNewswire/ — Air France has officially inaugurated…

China remains the main engine of global trade growth: Global Times editorial

BEIJING , Dec. 12, 2024 /PRNewswire/ — According to statistics recently released on…
RSNA 2024 Spotlight: Careverse Leads the New Trend in Medical AI

RSNA 2024 Spotlight: Careverse Leads the New Trend in Medical AI

CHICAGO, Dec. 12, 2024 /PRNewswire/ — From December 1st to 5th, 2024,…
Dstny appoints Vladan Petrovic as Group Chief People Experience Officer

Dstny appoints Vladan Petrovic as Group Chief People Experience Officer

BRUSSELS, Dec. 12, 2024 /PRNewswire/ — Dstny, the Belgian technology company that has…

Clarivate Launches AI-Powered Patent Search Solution in Derwent

Faster and more relevant results to empower critical IP decision-making LONDON, Dec.…

JA Solar's DeepBlue 4.0 Pro Wins "Very Good" Rating from PV Magazine Module Test

BEIJING, Dec. 12, 2024 /PRNewswire/ — JA Solar, a global leader in…